MEI Pharma Inc (MEIP)
3.13
+0.06
(+1.95%)
USD |
NASDAQ |
Nov 04, 12:58
MEI Pharma Price to Book Value: 0.6316 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 0.6195 |
| October 31, 2024 | 0.6255 |
| October 30, 2024 | 0.6275 |
| October 29, 2024 | 0.6397 |
| October 28, 2024 | 0.6225 |
| October 25, 2024 | 0.5509 |
| October 24, 2024 | 0.5519 |
| October 23, 2024 | 0.5529 |
| October 22, 2024 | 0.5549 |
| October 21, 2024 | 0.5529 |
| October 18, 2024 | 0.5589 |
| October 17, 2024 | 0.5549 |
| October 16, 2024 | 0.5589 |
| October 15, 2024 | 0.5468 |
| October 14, 2024 | 0.5388 |
| October 11, 2024 | 0.5448 |
| October 10, 2024 | 0.5448 |
| October 09, 2024 | 0.5408 |
| October 08, 2024 | 0.5468 |
| October 07, 2024 | 0.5589 |
| October 04, 2024 | 0.567 |
| October 03, 2024 | 0.5549 |
| October 02, 2024 | 0.5549 |
| October 01, 2024 | 0.565 |
| September 30, 2024 | 0.5751 |
| Date | Value |
|---|---|
| September 27, 2024 | 0.5852 |
| September 26, 2024 | 0.5852 |
| September 25, 2024 | 0.5771 |
| September 24, 2024 | 0.5953 |
| September 23, 2024 | 0.5912 |
| September 20, 2024 | 0.6013 |
| September 19, 2024 | 0.6336 |
| September 18, 2024 | 0.6134 |
| September 17, 2024 | 0.6054 |
| September 16, 2024 | 0.6154 |
| September 13, 2024 | 0.6114 |
| September 12, 2024 | 0.6175 |
| September 11, 2024 | 0.6094 |
| September 10, 2024 | 0.6247 |
| September 09, 2024 | 0.5953 |
| September 06, 2024 | 0.6255 |
| September 05, 2024 | 0.6356 |
| September 04, 2024 | 0.6255 |
| September 03, 2024 | 0.6316 |
| August 30, 2024 | 0.6255 |
| August 29, 2024 | 0.6578 |
| August 28, 2024 | 0.6275 |
| August 27, 2024 | 0.6417 |
| August 26, 2024 | 0.6417 |
| August 23, 2024 | 0.6336 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.363
Minimum
Jun 24 2024
11.94
Maximum
Nov 30 2021
3.032
Average
1.780
Median
Jun 30 2023
Price to Book Value Benchmarks
| Avid Bioservices Inc | 11.42 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.114 |
| Theriva Biologics Inc | 0.0745 |
Price to Book Value Related Metrics
| PE Ratio | 1.172 |
| PS Ratio | 0.1979 |
| Price | 3.13 |
| Earnings Yield | 85.30% |
| Market Cap | 20.85M |
| Operating PE Ratio | 0.5677 |
| Normalized PE Ratio | 0.5121 |